Evidence map›Paper›PMID 39290788›Full record

ArticleClinical, cosmetic and investigational dermatology2024

Turn Your AART into a HIT Using a Complete Range of Aesthetic Injectables: Methodology for Combining Products to Maximise Patient Outcomes.

Andreas Nikolis, Luiz Eduardo Toledo Avelar, Alessandra Haddad, Stephanie Chuk Kwan Lam, Andrei Metelitsa, Heidi B Prather, Frank Rosengaus, Kaitlyn M Enright, Desislava Ognyanova Lazarova, Inna Prygoya and 1 more

Abstract read
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Andreas NikolisClinical Research Unit, Erevna Innovations Inc, Westmount, Quebec, Canada.
Luiz Eduardo Toledo AvelarClinica Domani Luiz Avelar, Belo Horizonte, Minas Gerais, Brazil.
Alessandra HaddadFederal University of São Paulo and Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.
Stephanie Chuk Kwan LamCentral Health Medical Practice, Hong Kong, People's Republic of China.
Andrei MetelitsaDepartment of Dermatology, University of Calgary, Alberta, Canada.
Heidi B PratherWestlake Dermatology, Austin, TX, USA.
Frank RosengausDr. Rosengaus Clinic, Mexico City, Mexico.
Kaitlyn M EnrightClinical Research Unit, Erevna Innovations Inc, Westmount, Quebec, Canada.ORCID 0000-0001-6555-4838
Desislava Ognyanova LazarovaGalderma SA, Lausanne, Vaud, Switzerland.
Inna PrygoyaGalderma, Uppsala, Sweden.
Fabio IachettiGalderma, Uppsala, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Optimizing outcomes of aesthetic treatments with injectable products usually requires a consideration of the entire face to ensure balance, along with combination treatments that align with the patient's goals. To help injectors, a method of assessing the patient and developing an individualized, holistic treatment plan was developed. This methodology is termed Assessment, Anatomy, Range, and Treatment (AART™) and Holistic Individualized Treatments (HITs™). This article aims to describe and evaluate the novel and systematic AART-HIT™ methodology. Methods: The AART-HIT™ methodology, including its associated diagnostic tool the Facial Assessment Scale (FAS™), were developed to aid injectors in completing a patient assessment in which the entire face is evaluated, the relevant anatomy is considered, the science behind the available range of products is understood, and the treatment plan is individualised for the patient. Specifically, the HITs™ are methodologic tools for practitioners to perform a standardized, full facial assessment and to create an individualized treatment approach to holistically address a patient's aesthetic concerns. The use of this methodology in clinical practice was assessed via a survey, deployed to twenty-eight clinicians. Results: Over 85% of participants agreed that the AART-HIT™ methodology was adequate for their needs. Additionally, 100% of participants agreed that the temporal sequencing of HITs™ and the FAS™ diagnostic tool was useful in clinical practice. Furthermore, over 70% of participants agreed that the anatomical locations identified in each HIT™ were sufficient, while over 80% responded that the HITs™ adequately represented the range of products. Finally, over 85% of participants agreed that the HITs™ covered different ethnic skin types and various patient ages and, over 80% of participants responded that they would not add additional elements to any of the 5 HITs™. Conclusion: The AART-HIT™ methodology, including the FAS™ were comprehensive enough for clinical use in providing a personalised treatment plan for individual patients.

Indexed as

biostimulatorseducationfillershyaluronic acidneuromodulatorstreatment techniques

Identifiers

PMID39290788
PMCPMC11407320

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.